Company Profile
Gingko Bioworks Stock Price, News & Analysis
- Ticker:
- SRNGU
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
11.97 USD
Close
Last updated: September 16, 2021 at 00:00
—
Market cap
Why the stock is moving
SRNGU is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Gingko Bioworks is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Gingko Bioworks is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Gingko Bioworks follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Gingko Bioworks sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
- 03
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
ENLV · Source: Enlivex Therapeutics
- 04
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 05
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Gingko Bioworks (SRNGU)?
Gingko Bioworks (SRNGU) most recently closed at 11.97 USD.
What does Gingko Bioworks do?
Gingko Bioworks is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is SRNGU stock listed?
Gingko Bioworks (SRNGU) is associated with NASDAQ, United States, Biotechnology.
What is Gingko?
Gingko Bioworks is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Gingko Bioworks targeting with Gingko?
Gingko Bioworks is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Bioworks?
Gingko Bioworks is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.